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1. Introduction 
Cardiac rhythm management devices are being increasingly implanted worldwide not only 
for symptomatic bradycardia, but also for the management of arrhythmia and heart failure 
(Adabag et al. 2011; COMPANION Investigators 2004; Multicenter Automatic Defibrillator 
Implantation Trial Investigators 1996; Sudden Cardiac Death in Heart Failure Trial 
Investigators 2005). The benefit of cardiac resynchronization therapy (CRT) with permanent 
pacemakers (PPM) as first invasive step to treat the failing heart (Adabag et al. 2011; 
COMPANION Investigators 2004) and the survival advantage of internal cardiac 
defibrillator (ICD) in patients with end stage heart failure compared with medical therapy 
alone (Multicenter Automatic Defibrillator Implantation Trial Investigators 1996; Sudden 
Cardiac Death in Heart Failure Trial Investigators 2005), have supported a more liberal 
implantation policy of these devices. Moreover the widespread use of the trans-catheter 
aortic valve implantation (TAVI) for the percutaneous treatment of severe aortic stenosis, in 
high risk patients that would, otherwise, deemed inoperable by conventional surgery, has 
carried along a high post procedural implantation rate of PPMs in this elderly subgroup of 
patients (Bates et al. 2011; D'Ancona et al. 2011). It seems logical to expect an increased rate of 
device related infections to follow the boom of PPMs and ICDs implantation in the last two 
decades (Voigt et al. 2006). Of the 400,000 -500,000 permanent pacemaker leads implanted 
worldwide each year, around 10% may eventually fail or become infected, becoming potential 
candidates for removal (Byrd et al. 1999). Device infections can be local, involving the insertion 
site of PPM or ICD box, or systemic because of the spreading along the PPM leads  and, in 
worst case scenario, lead to septic shock and device-related endocarditis. Device-related 
endocarditis has been reported in 23% of infected PPMs, the remainder being pocket infections 
(Sohail et al. 2007). The infection can spread over the cardiac structures and typically involves 
the tricuspid valve. Right-sided endocarditis accounts for only 5–10 % of cases of infective 
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endocarditis (Chan et al. 1989) and occurs predominantly in selected patient’s subgroup, such 
as: intravenous drug users, patients with pacemakers, ICD or central venous lines and with 
congenital heart diseases (Robbins et al. 1986). The tricuspid valve can show massive 
vegetations with or without valve regurgitation (figure 1). 
 
LA: left atrium; LV: left ventricle; RA: right atrium; RV: right ventricle. 
Figure 1. 1Transesophageal echocardiography –four chamber view - shows multiple vegetations on the 
tricuspid valve (long arrow) and pacing leads (short arrow).  
This chapter will focus on the presentation, diagnosis and management of device-related 
endocarditis and explore different extraction techniques - both percutaneous and surgical. 
2. Device-related endocarditis 
Mortality rates for infected PPM devices range from 31% to 66% when the device is not 
explanted (Cacoub et al. 1998). Better outcomes, with mortality rates of 18% or less, have 
been reported when a combined management with device removal and antimicrobial 
therapy is adopted (Klug et al. 1997). Pacemaker related sepsis or endocarditis is a class I 
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indication for lead extraction, according to the recently updated device infection guidelines 
(Baddour et al. 2010). Standard treatment includes removal of infected PPM device 
combined with six weeks of antimicrobial therapy. Management of device-related 
endocarditis is challenging and requires collaborative efforts between cardiologists, 
surgeons, and infective disease specialists. 
2.1. Clinical presentation 
The presentation can be acute, with onset of symptoms in the first 6 weeks after the last 
procedure on the implant site, or chronic, with >6 weeks from the last procedure on the 
implant site to the onset of symptoms. In the acute form, the short time elapsed between PM 
implantation and the occurrence of infection facilitates the diagnosis. The vast majority of 
patients will have systemic symptoms from septic shock to fever, pneumonia, pulmonary 
embolism, associated with local signs of infection at the PM site. In the chronic form, the 
delay between the onset of symptoms and the implant time makes it difficult to diagnose 
PM-lead infection. Often delays in diagnosis of chronic device-related endocarditis are 
related to the fact that PM-lead infection was not considered in the differential diagnosis or 
because, possible clues were ignored: for example, blood cultures positive for S. epidermidis 
were erroneously considered contamination of the specimens (Klug et al. 1997). The most 
common chronic presentation would be fever or chills with asthenia, and wasting, 
sometimes associated with symptoms and signs of low tract respiratory infection (cough, 
expectoration, bronchitis, pneumonia, pulmonary abscess, pleural effusion). History of 
pulmonary embolism, arthralgia, spondylitis or signs of local infection at the PM site could 
be present. The diagnosis of systemic infection related to PM-lead infection must be 
systematically considered in the presence of chronic fever, recurrent bronchitis, or 
pulmonary infection or in case of recurrent or persistent evidence of infection at the implant 
site (Klug et al. 1997). More over endocarditis of the right heart should be specifically 
excluded, regardless the presence or absence of tricuspid regurgitation (Love et al. 2000). 
2.2. Diagnosis  
Patients will have elevated markers of inflammation. Erythrocyte sedimentation rate (ESR) 
and CRP will be elevated, often along with high withe cell count (WCC) due to an increase 
in polymorphonuclear cells. Positive blood cultures will confirm the diagnosis. Blood 
cultures should be taken on 3 consecutive days and integrated with cultures at the site of 
battery pocket if appropriate (wounds, local infection, or PM exteriorization). The Duke 
criteria are useful to define systemic infection related to PM-lead infection (tab.1), but as 
suggested by Klug et al (1997), the importance of some clinical criteria, should, probably, be 
highlighted, such as, local symptoms of infection at the PM site and pulmonary infections, to 
facilitate the diagnosis (tab.2). 
Chest roentgenogram will often show signs of pulmonary infection or pleural effusion. 
Echocardiography is essential to confirm the diagnosis and to clarify whether treatment will 
require removal of the infected pacing system. However, a single negative transthoracic 
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echocardiogram (TTE) is not enough to exclude the diagnosis of lead-related endocarditis. 
Although TTE has about 80% sensitivity in the detection of vegetations in the right heart 
(Love et al. 2000), often patients present with PM-lead–related endocarditis with intact 
tricuspid leaflets (Klug et al. 1997). This is the reason why a transoesophageal 
echocardiogram (TOE) should always be performed in the diagnostic algorithm when 
device-related endocarditis is suspected. Ventilation perfusion pulmonary scintigraphy can 
corroborate the diagnosis showing multiple septic lung embolisms. It is wise to perform also 
a wider range of investigations to exclude other sources of infection. These will normally 






Microorganisms: demonstrated by culture or histology in vegetation, in a vegetation that 
has embolized, or in intracardiac abscess, or  
Microorganisms demonstrated by culture of the lead 
Clinical criteria(as listed in Table 2) 
Two major criteria, or 
One major and three minor criteria, or 
Five minor criteria 
Possible infective endocarditis
Findings consistent with infective endocarditis that fall short of "definite" but not 
"rejected" 
Rejected 
Firm alternate diagnosis explaining evidence of infective endocarditis, or 
Resolution of infective endocarditis syndrome, with antibiotic therapy for ≤4 days, or  
No pathological evidence of infective endocarditis at surgery or autopsy, with antibiotic 
therapy for ≤4 days  
 
 
Table 1. 2 Modified Duke Criteria for Diagnosis of Infective Endocarditis on PM Leads 
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Major criteria 
Positive blood culture for infective endocarditis
Typical microorganisms for infective endocarditis from two separate blood cultures 
Streptococcus viridans, Streptococcus bovis, HACEK group, or 
Community-acquired Staphylococcus aureus or enterococci, in the absence of a primary 
focus, or  
Persistently positive blood culture, defined as microorganism consistent with infective 
endocarditis from Blood cultures drawn >12 hours apart, or
All of three or a majority of four or more separate blood cultures, with first and last 
drawn at least 1 hour apart
Evidence of endocardial involvement:
Positive echocardiogram for infective endocarditis:
Oscillating intracardiac mass on PM leads or on the endocardial structure in contact with 
PM leads 
Abscess in contact with PM leads
Minor criteria 
Fever >38°C 
Vascular phenomena: arterial embolism, septic pulmonary infarcts, mycotic aneurysm, 
intracranial hemorrhage, Janeway lesions
Immunologic phenomena: glomerulonephritis, Osler nodes, Roth spots
Echocardiogram: consistent with infective endocarditis but not meeting major criterion as 
noted previously (sleevelike appearance)
Microbiological evidence: positive blood culture but not meeting major criterion as noted 
previously. 
Table 2. 3 Definition of Terms Used in the Proposed Modified Diagnostic Criteria 
2.3. Pathophysiology  
It is commonly accepted that the most common portal of entry to develop device-related 
endocarditis is the subcutaneous site of insertion of the pacing system. Extension along the 
lead into the vascular system is the usual explanation for the localization of the infection to 
the lead. Bacterial colonization of the lead during the course of bacteremia whose origin is 
not related to the pacing system might be possible but has been less well documented. 
Staphylococci are responsible for the vast majority of these infections, especially S. 
epidermidis in the chronic group and S. aureus in the acute group. A fungal infection is rare 
and more subtle to indentify. Fungal endocarditis is associated with high mortality and 
usually presents with scant growth of the microorganism in blood cultures (Figure 2). A 
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high index of suspicion for fungal endocarditis should be maintained in individuals with 
implantable pacemakers and fever of an uncertain source, especially in the context of 
negative blood cultures(Leong 2006). However, there is a 20-30% of device-related 
endocarditis with negative BC (Klug et al. 1997). 
 
Figure 2. 4A: Transthoracic echocardiogram of the right atrium (RA), tricuspid valve (TV) and right 
ventricle (RV) demonstrating a pacemaker lead (P) and no valvular vegetations. B: Second transthoracic 
echocardiogram of the right heart, seven weeks after the initial echocardiogram, demonstrating a right 
ventricular pacemaker lead thrombus (Th) 
2.4. Management  
The removal of the entire pacing system should be performed immediately rather than 
attempting prolonged antibiotic therapy alone. As in the study by Camus et al, the high rate 
of uncontrolled infection or relapse among patients with septicemia in relation to PM-
material infection confirms the need for (Camus et al. 1993). Moreover immediate removal 
of the entire pacing system should be performed in all cases both for systemic infection 
related to PM-lead contamination and for infection of the PM pocket or the subcutaneous 
part of the lead (Panidis et al. 1984). Cultures of the leads and of the PM should be done 
after the extraction.Complete PPM or ICD removal should be performed when patients 
undergo valve replacement or repair for infective endocarditis, because the pacing system 
could serve as a nidus for relapsing infection and subsequent seeding of the surgically 
treated heart valve. Hardware removal is not required for superficial or incisionalinfection 
at the pocket site if there is no involvement of the device, 7-10 days of antibiotic therapy 
with an oral agent with activity against staphylococci is reasonable (Baddour 2010). 
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3. Technique of extraction: Surgical or percutaneous? 
After implantation, transvenous device leads usually undergo fibrotic encapsulation by 
activation of different cellular and humoral mechanisms (Esposito et al. 2002). The ensuing 
fibrotic lead adhesions tend to increase over time. Young patients, however, usually develop 
fibrotic adhesions earlier than elderly. On the contrary, systemic lead infection seems to 
counteract or dissolve fibrotic adherences. Current literature suggests that, the best outcome 
is achieved with percutaneous removal of infected devices by applying external traction on 
the leads (Sohail et al. 2007; Ruttmann et al. 2006). However, while simple traction is often 
successful in newly placed leads, it can be problematic with chronic leads and cause 
catastrophic complications, ranging from septic embolic phenomena to tricuspid valve 
injury, subclavian vein laceration, hemothorax, pocket hematoma, massive hemorrhage, and 
lead fracture requiring urgent surgical intervention (Sohail et al. 2007; Ruttmann et al. 2006; 
Panidis et al. 1984). Damage to the left sided cardiac structures is rare but may be a 
complication of an infected lead extraction, manifesting as iatrogenic ventricular septum 
disruption with consequent aortic valve leaflet prolapse and massive acute aortic 
regurgitation (fig.3)(Rossi et al. 2011). 
Chronically implanted leads are fixed to the myocardium by fibrous tissue. Fibrous scar 
tissue may also encase the lead along its course. Furthermore, fragility of the lead and its 
tendency to break when extraction force is applied to overcome resistance imparted by the 
scar tissue add to the challenge of lead extraction. Thus, selecting the appropriate extraction 
procedure for chronically implanted leads is an important issue. 
3.1. Percutaneous extraction  
The removal of the entire pacing system should be performed in one session. 
Newpercutaneous PM and ICD lead extraction techniques have been developed to 
overcome the problem of a difficult extraction with the aim to reduce damage to the cardiac 
structures produced by the simple counter traction. Telescoping mechanical sheaths and 
locking stylets were introduced during the late 1980s and early 1990s. Special tools for 
femoral lead extraction soon followed. They can be used though a superior approach 
(jugular or subclavian vein) using locking stylet ; or via a femoral vein approach using 
double lasso catheters (Needle's eye snare) (Byrd et al. 1999; Bracke et al. 2001; Fearnot et al. 
1990). In the superior vena cava approach, a locking stylet is introduced into the lead and 
locked close to the distal electrode in order to apply traction directly to the tip. If gentle 
traction is not successful, telescoping sheaths can be advanced over the lead to disrupt 
fibrous binding of the lead to veins or myocardium. When necessary, the tip of the lead is 
freed by countertraction, the sheath being positioned against the myocardium to prevent 
inversion during traction on the lead. In the transfemoral approach, the pacing lead is 
grabbed with a deflecting guide wire or retriever through a long sheath inserted from the 
femoral vein. The proximal end of the lead is pulled down from the subclavian vein. Then 
the outer sheath is advanced over the lead to disrupt the scar tissue, as with the superior 
approach. When the myocardium is reached countertraction is applied. 
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AV: aortic valve; MV: mitral valve; PV: pulmonary valve; TV: tricuspid valve.  
Figure 3. 5 Four-valve view of the fibrous skeleton of the heart showing disruption of the tricuspid 
valve (long black arrow), ventricular septal defect (white arrow), and prolapse of the noncoronary cusp 
of the aortic valve (short black arrow).  
3.1.1. Laser extraction 
Progress has also been made in developing other systems for lead extraction powered with 
laser energy. The first laser-assisted lead extraction performed in 1994 was a major 
breakthrough. The laser extraction sheath offers a method for removal by "cutting" through 
scar tissue, without excessive use of force (such as with purely mechanical systems). It 
appears to be an efficient tool for removal of chronic implanted infected leads but its use is 
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 Intraoperative cultures of the aortic valve and ventricular septal defect edges did not show any significant growth, 
supporting the hypothesis that the prolapse of the noncoronary cusp was due to lack of support on the valve structure. 
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associated with a high number of bleeding complications often requiring surgical revision 
(see section 3.3). 
3.2. Surgical extraction  
Surgical removal has a higher complication rate and worse outcome compared with 
percutaneous techniques (Klug et al. 1997). Although, in concept, the surgical approach is 
the cleanest way to extract an infected lead together with its vegetation without risks of 
pulmonary or systemic septic embolism,  it is generally accepted both by surgeon and 
cardiologist to prefer the percutaneous extraction as first attempt. However we should not 
forget that the surgical population is highly selected, i.e. made of cases not suitable for 
percutaneous extraction or with heart damage after percutaneous attempt or with severe 
tricuspid valve involvement. Moreover, the presence of intracardiac vegetations alone, 
identifies a subset of patients at increased risk for complications and early mortality from 
systemic infection regardless the technique of extraction (percutaneous or surgical) and 
appropriate antimicrobial therapy (Grammes et al. 2010). From a review of the current 
literature, it appears that the indication for surgical removal is mainly limited as rescue 
intervention to fix complicated or failed percutaneous extraction. Surgical removal generally 
requires median sternotomy or thoracotomy and sometimes cardiopulmonary bypass (CBP). 
Nevertheless there are still patients that will benefit from a surgical removal as a first 
attempt rather than later, especially those with large vegetations that might obstruct the 
main pulmonary artery or those who need the implantation of an epicardial pacing system.  
A primary surgical approach to lead removal in patients with PPM/ICD infection is 
recommended by the current guidelines for implantable electronic device infections and 
management in patients who have significant retained hardware after attempts at 
percutaneous removal or in patients with lead vegetations > 2 cm in diameter, because of 
concerns about the risk of pulmonary embolism with percutaneous lead extraction (Baddour 
et al. 2010). In fact, it is useful to reconsider the indication for pacing after successful 
extraction of the infected pacing system.Discontinuation of pacemaker treatment after lead 
extraction has been reported in 13–52% of patients (Bracke et al. 2001). However when 
permanent pacing is a must, an epicardial system is the recommended choiceespecially after 
valve surgery with initial hardware removal(Baddour et al. 2010). With the surgical 
approach, the epicardial permanent system can be easily placed at the same time of the 
extraction and offers the advantage of eliminating the contact between leads and systemic 
circulation taking the chances of infection of the new system to the ground.  
3.3. Evidence-based discussion  
Wilkoff  et al, in a randomized control trial of 465 chronically implanted leads, achieved 94% 
complete removal with a laser sheath against 64% with conventional sheaths, but with an 
higher rate of potentially life-threatening complications (Wilkoff et al. 1999). In a multicenter 
study over 2338 patients, Byrd et al, reported an increased risk of failed or partial extraction 
with increasing implant duration, doubling every three years (Byrd et al. 1999). Kennergren 
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et al, in a retrospective analysis of their activity on 647 lead extractions, surprisingly showed 
that the implantation time was not associated with extraction failure neither there was an 
association between implantation time and the incidence of serious complications. Actually 
they showed that leads can often be extracted by a superior transvenous approach with 
simple traction; Laser-assisted lead extraction appeared to be a useful technique to extract 
leads that could not be removed by manual traction but at the cost of a higher rate of 
bleeding complications requiring open-chest surgical revision (Kennergren et al. 2009). Alt 
et al, achieved total removal of 81% of 150 leads, without major complications with the use 
of only locking stylets (Alt et al. 1996). Tokunaga et al, performed a surgical removal without 
CBP after a failed extraction using the Excimer Laser Sheath Extraction System (Tokunaga et 
al. 2011). The authors highlight the potential risk of perforation and lethal bleeding 
complications using this tool and suggest a close backup by a cardiovascular surgeon. Neuzi et 
al, in a randomized control trial (RCT) compared the safety and efficacy of transvenous 
pacemaker and implantable cardioverter-defibrillator (ICD) lead extraction, with an 
electrosurgical dissection sheath (EDS) system using radiofrequency (RF) current or standard 
countertraction lead removal in 120 consecutive patients (Neuzi et al. 2007). Although the 
EDS extraction system appeared quicker and more effective in complete removal of leads, they 
could not demonstrate a significant superiority versus the standard counter-traction method. 
Buongiorni et al, in a retrospective analysis of 1330 leads extraction, concluded that 
transvenous lead extraction is an effective and safe procedure. They showed how the use of 
the jugular approach, in the presence of free-floating or difficult exposed leads, increases both 
safety and success rate (Buongiorni et al. 2005). Kratz et al, in a retrospective analysis of 365 
patients who underwent PPM or ICD lead removal, showed that performing 
a lead extraction in a protected environment, such as an operating room, allowed rapid and 
effective treatment of potential procedure-related complications. Actually, the use of 
several extraction tools, arterial line monitoring, transesophageal echocardiography, general 
anesthesia, and an experienced team, yielded complete extraction in more than 90% of 
patients, with a low complication rate and no procedurally related deaths (Kratz et al. 2010). 
Grammes et al, reported their experience using percutaneous leads extraction by simple 
traction of 1,838 infected leads with echocardiographic evidence of intracardiac vegetations. 
Post-operative 30-day mortality was 10%; no deaths were related directly to 
the extraction procedure (Grammes et al. 2010). The common message that comes from the 
literature is that  extraction of infected PM-leads is not just a ”pull and go” procedure and 
should be performed by expert physicians, in tertiary centres, with a cardiac surgery back up 
to best  manage their complications. 
3.3.1. Septic embolism  
There is also a concern in pacemaker related endocarditis over embolisation of vegetations 
adhering to the lead when endovascular extraction is attempted. Klug et al, in their series of 
52 patients with device-related endocarditis, suggested to chose the technique of removal 
(surgical versus percutaneous) on the size of the vegetations: percutaneous when vegetation 
size was ≤10 mm and surgical if > 10mm at transesophageal echocardiogram (Klug et al. 
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1997). This policy was based on previous observations by Mugge et al and by Robbins et al, 
who found that embolism was more frequent with vegetation size was >10 mm in 
endocarditis related to valve infection (Mugge et al. 1989; Robbins et al. 1986). More recently 
Ruttmann et al, showed that transvenous lead removal is a safe and effective even in 
patients with large vegetations. Embolism to the lung happens but  tends to proceed mainly 
without complications. However there are still cases where surgical approach is preferred, 
such as, in presence of large vegetations that might occlude the main pulmonary 
artery(Ruttmann et al. 2006) or with vegetations > 2 cm in diameter (Baddour et al. 2010). 
4. Conclusion  
The diagnosis of endocarditis related to PM-lead infection should be systematically 
considered in patients with fever, history of local complications, or pulmonary pathology 
after PM insertion. There are two different clinical presentations: the acute form, that 
presents early with sepsis, often in conjunction with local signs of infection, and a chronic 
form, beginning several months later. The presentation may be atypical and the symptoms 
may occur late after the last intervention at the PM site. CRP, ESR, scintigraphy or chest CT 
angiogram may be of diagnostic value. TTE and TOE must be performed in search of 
vegetations. Immediate removal of the entire pacing system is paramount, in addition to 
prolonged antimicrobial therapy. We believe that multidisciplinary approach is the key to 
manage device-related endocarditis and good professional relationships are essential 
between cardiologists, surgeons, and infective disease specialists to make the appropriate 
decisions to best treat these complex patients. Our recommendation, in the patients’ best 
interest, is not to embark on extracting infected leads without doing a serious ongoing 
individual risk–benefit analysis. Finally a word of wisdom to the future generations: even if 
we are moving faster towards new innovative ways to pace the heart, we will always be 
dealing with their complications, therefore, is worth to create a network of professionals to 
address them in the best possible way.  
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